Skip to main navigation Skip to search Skip to main content

Clinical and Serological Characterization of Orf-Induced Immunobullous Disease

  • Kaan Yilmaz
  • , Stephanie Goletz
  • , Henri H. Pas
  • , Renate R. Van Den Bos
  • , Andrew Blauvelt
  • , Wain L. White
  • , Jean David Bouaziz
  • , Elina Zuelgaray
  • , Maryam Daneshpazhooh
  • , Kim B. Yancey
  • , Matthias Goebeler
  • , Enno Schmidt*
  • *Corresponding author for this work
  • University of Lübeck
  • University of Groningen
  • Oregon Health and Science University
  • Aurora Diagnostics GPA Laboratories
  • Université Paris Cité
  • Tehran University of Medical Sciences
  • University of Texas Southwestern Medical Center
  • University of Würzburg

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)

Abstract

Importance: Ecthyma contagiosum, or orf, is a viral zoonotic infection caused by Poxviridae. Although human orf infection is considered to follow a self-limited course, various immunological reactions may be triggered, including immunobullous diseases. In the majority of the latter cases, the antigenic target remained enigmatic. Objective: To characterize the predominant autoantigen in orf-induced immunobullous disease and further describe this clinical entity. Design, Setting, and Participants: This multicenter case series sought to provide detailed clinical, histopathological and immunological characteristics of a patient with orf-induced pemphigoid. Based on this index patient, serological analyses were conducted of 4 additional patients with previously reported orf-induced immunobullous disease. Immunoblotting with extracellular matrix and a recently established indirect immunofluorescence assay for detection of serum anti-laminin 332 IgG were performed. Exposures: The disease course and clinical characteristics of orf-induced immunobullous disease were observed. Main Outcomes and Measures: Orf-induced immunobullous disease is primarily characterized by anti-laminin 332 autoantibodies, predominant skin involvement, and a self-limiting course. The study provides further details on epidemiological, clinical, immunopathological, diagnostic, and therapeutic aspects of orf-induced immunobullous disease. Results: In all 5 patients, IgG1 and/or IgG3 autoantibodies against laminin 332 were identified. The α3, β3, and γ2 chains were recognized in 2, 4, and 1 patient(s), respectively. Conclusions and Relevance: In this case series, laminin 332, a well-known target antigen in mucous membrane pemphigoid, was a major autoantigen in orf-induced immunobullous disease, even though predominant mucosal lesions were lacking in this autoimmune blistering disease. Orf-induced anti-laminin 332 pemphigoid is proposed as distinct clinical entity..

Original languageEnglish
Pages (from-to)670-674
Number of pages5
JournalJAMA Dermatology
Volume158
Issue number6
Early online date30 Mar 2022
DOIs
Publication statusPublished - Jun 2022

Bibliographical note

Funding Information:
supported by structural funding from the Deutsche Forschungsgemeinschaft (DFG) through CRU 303 Pemphigoid Diseases and the Excellence Cluster 2167/1 Precision Medicine in Chronic Inflammation (to Dr Schmidt).

Publisher Copyright:
© 2022 American Medical Association. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Clinical and Serological Characterization of Orf-Induced Immunobullous Disease'. Together they form a unique fingerprint.

Cite this